Joseph Klein's most recent trade in Ionis Pharmaceuticals Inc was a trade of 13,526 Common Stock done at an average price of $79.2 . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 79.17 per share. | 03 Mar 2026 | 13,526 | 18,820 (0%) | 0% | 79.2 | 1,070,908 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.05 per share. | 03 Mar 2026 | 12,000 | 28,346 (0%) | 0% | 40.1 | 480,600 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 12,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 79.99 per share. | 03 Mar 2026 | 6,794 | 12,026 (0%) | 0% | 80.0 | 543,486 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.88 per share. | 03 Mar 2026 | 4,000 | 32,346 (0%) | 0% | 42.9 | 171,520 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 4,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 80.82 per share. | 03 Mar 2026 | 1,012 | 11,014 (0%) | 0% | 80.8 | 81,788 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 4,000 | 4,000 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 25 Nov 2025 | 4,000 | 0 (0%) | 0% | 80 | 320,000 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 4,000 | 4,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 4,000 | 8,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 4,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 25 Nov 2025 | 4,000 | 0 (0%) | 0% | 80 | 320,000 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 4,000 | 4,000 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 25 Nov 2025 | 4,000 | 0 (0%) | 0% | 80 | 320,000 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 4,000 | 4,000 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 03 Sep 2025 | 28,000 | 0 (0%) | 0% | 60 | 1,680,000 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 03 Sep 2025 | 28,000 | 0 (0%) | 0% | 60 | 1,680,000 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 16,000 | 16,000 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 16,000 | 16,000 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 12,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 12,000 | 28,000 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 12,000 | 28,000 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 12,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 11,518 | 11,518 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 5,220 | 13,976 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 16 Jul 2024 | 12,000 | 12,000 (0%) | 0% | 24.4 | 293,040 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 12,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 16 Jul 2024 | 12,000 | 0 (0%) | 0% | 50 | 600,000 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 10,111 | 10,111 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 4,079 | 8,756 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 42.57 per share. | 03 May 2024 | 1,318 | 4,682 (0%) | 0% | 42.6 | 56,110 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 42.59 per share. | 03 May 2024 | 1,269 | 2,731 (0%) | 0% | 42.6 | 54,044 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 42.55 per share. | 03 May 2024 | 1,070 | 930 (0%) | 0% | 42.5 | 45,526 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 03 May 2024 | 930 | 0 (0%) | 0% | 42.9 | 39,893 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 42.98 per share. | 03 May 2024 | 731 | 2,000 (0%) | 0% | 43.0 | 31,416 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 42.94 per share. | 03 May 2024 | 682 | 4,000 (0%) | 0% | 42.9 | 29,288 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 23,901 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 4,677 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 17 Jul 2023 | 3,555 | 20,346 (0%) | 0% | 42 | 149,310 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,777 | 10,010 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,777 | 18,568 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 10,321 | 10,321 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 4,677 | 11,787 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 17 Jan 2023 | 2,000 | 16,791 (0%) | 0% | 40 | 80,000 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 5,333 | 9,775 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 5,333 | 17,459 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,665 | 20,124 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,665 | 7,110 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 37.74 per share. | 15 Jul 2022 | 689 | 19,435 (0%) | 0% | 37.7 | 26,003 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Sale of securities on an exchange or to another person at price $ 38.78 per share. | 15 Jul 2022 | 644 | 18,791 (0%) | 0% | 38.8 | 24,974 | Common Stock |
| Ionis Pharma Inc | Joseph Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 5,333 | 15,108 | - | - | Restricted Stock Unit | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 12 Jan 2022 | 371,760 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 12 Jan 2022 | 371,760 | 441,760 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 183,783 | 260,183 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 183,783 | 12,895 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 70,000 | 70,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 70,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 68,577 | 336,760 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 68,577 | 11,423 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 35,000 | 371,760 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 8,000 | 268,183 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 8,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 6,400 | 76,400 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 6,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 09 Nov 2021 | 70,000 | 70,000 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 09 Nov 2021 | 70,000 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 70,000 | 70,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 183,322 | 196,678 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 145,626 | 114,374 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 94,922 | 215,078 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 50,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 35,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 6,400 | 6,400 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 18 Aug 2021 | 4,000 | 4,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 75.69 per share. | 13 Aug 2021 | 196,021 | 0 | - | 75.7 | 14,836,633 | Class A Common Stock |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 100,000 | 100,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 13 Aug 2021 | 100,000 | 100,000 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 100,000 | 260,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 13 Aug 2021 | 100,000 | 100,000 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 13 Aug 2021 | 50,000 | 150,000 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 50,000 | 310,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 50,000 | 150,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 13 Aug 2021 | 50,000 | 50,000 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 13 Aug 2021 | 30,000 | 200,000 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 30,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 30,000 | 200,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 13 Aug 2021 | 30,000 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 13 Aug 2021 | 20,000 | 170,000 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 20,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 20,000 | 170,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Joseph Kleine | Chief Commercial Officer | 13 Aug 2021 | 20,000 | 30,000 | - | - | Class B Common Stock |